AstraZeneca hit after psoriasis drug linked to suicide fears
 

AstraZeneca hit after psoriasis drug linked to suicide fears
LONDON, May 26 (Reuters) - AstraZeneca's hopes of topping $45 billion in revenue by 2023 have been dealt a blow by a problem with an experimental psoriasis drug that the drugmaker had viewed as a...http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...0w:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...0w:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/v_ETFB1MUGc